The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.


Updates from The Motley Fool

Latest updates on Illumina from Fool.com.


Stock Performance

ILMN vs. S&P 500 | 2 Year Performance
View Interactive ILMN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Illumina.
Current Price: $168.99
Prev Close: $170.42
Open: $170.50
Bid: $168.40
Ask: $169.50
Day's Range: $167.89 - $170.99
52wk Range: $127.10 - $213.27
Volume: 577,128
Avg Vol 1,230,131
Market Cap: $24.74B
P/E (ttm): 58.36
EPS (ttm): $2.92
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Illumina.
CAPS Rating 5 out of 5
 
1051 Outperform
55 Underperform
CAPS All Stars
 
269 Outperform
13 Underperform

How do you think Illumina will perform against the market?



You pick for Illumina is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Francis deSouza, CEO

100% Approve

Based on 12 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Illumina.

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers